ArticlePharmaceutics2024

Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)-Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems.

Damiana Scuteri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.